Latest literature | Zhongnan Medical Journal Press

Home Literature Latest literature

Latest literature

A case report on the pharmacological management of post-liver transplantationCandida aurisbloodstream infection

Published on Frontiers in Pharmaceutical Sciences 2026,30(7):1256-1260.
406 times 90 times

LAI Xiaomin CHEN Fanghui ZHANG Xiaojuan YU Hongxiu YANG Jian

Post-liver transplantation Candida auris Caspofungin Amphotericin B liposome Pharmaceutical care
Details
Advances in nevirapine drug delivery systems

Published on Frontiers in Pharmaceutical Sciences 2026,30(7):1250-1255.
397 times 74 times

REN Jinmei WANG Jing

Nevirapine Drug delivery system Nanotechnology Solid dispersion Targeted delivery Long-acting formulation
Details
Research progress on the prevention and treatment of radiation-induced lung injury with medicinal and edible Chinese herbs

Published on Frontiers in Pharmaceutical Sciences 2026,30(7):1238-1249.
415 times 92 times

ZHANG Xinling ZHANG Jiaxuan ZHANG Yu HOU Wenbin SHANG Haihua LI Yiliang

Medicinal and edible Chinese herbs Radiation-induced lung injury Prevention and treatment Radiation pneumonitis Radiation-induced pulmonary fibrosis Glycyrrhiza uralensis Angelica sinensis Astragalusmembranaceus
Details
Analysis of the current situation and development of the research onPeperomia dindygulensis based on bibliometrics

Published on Frontiers in Pharmaceutical Sciences 2026,30(7):1230-1237.
401 times 99 times

WANG Heshan LI Qianhong XIE Zixin WANG Kaige LI Huang FAN Shiming WU Shuisheng

Peperomia dindygulensis Bibliometrics CiteSpace Visualization analysis Secolignans Peperomine Cluster analysis
Details
Analysis of characteristics for SGLT2 inhibitor-associated Fournier gangrene based on the FAERS database

Published on Frontiers in Pharmaceutical Sciences 2026,30(7):1223-1229.
416 times 91 times

TAN Wanli LI Dan YAO Huijuan

Sodium-glucose co-transporter 2 inhibitor Fournier gangrene Adverse drug reaction Data mining FDA Adverse Event Reporting System database
Details
Data mining and risk profile construction of ravulizumab adverse events based on severity stratification

Published on Frontiers in Pharmaceutical Sciences 2026,30(7):1213-1222.
412 times 93 times

OU Dan ZHOU Zhou

Ravulizumab Serious adverse events Data mining FAERS database
Details
Mining and analysis of adverse event signals related to bosutinib based on the AEMS database

Published on Frontiers in Pharmaceutical Sciences 2026,30(7):1205-1212.
424 times 87 times

DI Panpan XING Xiaoqin LIANG Hai JIA Shuyun XIA Runan HU Yunfei

Bosutinib Adverse drug event Data mining Adverse Event Monitoring System database
Details
Identification of safety signals for antiepileptic drug-associated thrombocytopenia in minor population utilizing the FAERS database

Published on Frontiers in Pharmaceutical Sciences 2026,30(7):1196-1204.
444 times 99 times

DUAN Difan CHEN Yan LIN Gaoyang QIAN Mengying SHAN Qing GUO Jinmin

Thrombocytopenia Antiepileptic drugs Minor population Food and Drug Administration Adverse Event Reporting System Adverse drug event Signal mining
Details
Simultaneous determination of 4 anti-infective drug concentrations in human plasma by LC-MS/MS

Published on Frontiers in Pharmaceutical Sciences 2026,30(7):1187-1195.
446 times 92 times

FU Yao QIAN Zhengyue AO Hui CAO Jianfeng LI Jing

Liquid chromatography-tandem mass spectrometry Plasma drug concentration Imipenem Meropenem Posaconazole Colistin E Therapeutic drug monitoring
Details
Assessment of the impact of continuous renal replacement therapy on imipenem pharmacokinetics and clinical efficacy in critically ill patients via therapeutic drug monitoring

Published on Frontiers in Pharmaceutical Sciences 2026,30(7):1178-1186.
513 times 121 times

ZHANG Li CHEN Yuan HU Miao WAN Panting LIU Pingyu

Imipenem Continuous renal replacement therapy Therapeutic drug monitoring Pharmacokinetics/pharmacodynamics Individualized dosing
Details
Validation of virus inactivation/removal efficacy in production process of transfer factor solution

Published on Frontiers in Pharmaceutical Sciences 2026,30(7):1170-1177.
498 times 122 times

XUE Meiling GUO Weizhen WANG Hongxin WANG Chuanli CHEN Meihong WEI Xiaoliang

Transfer factor solution Virus inactivation Virus removal Pasteurization Ultrafiltration membrane filtration method
Details
Determination of 6 components in compound asiatic moonseed, paracetamol, and chlorphenamine maleate tablets by SPE-HPLC

Published on Frontiers in Pharmaceutical Sciences 2026,30(7):1163-1169.
514 times 131 times

QIAN Yujuan XIAO Honghua YUN Xiaofei HAN Feng ZHANG Yanxia YAN Zeman

Solid-phase extraction HPLC Compound asiatic moonseed paracetamol and chlorphenamine maleate tablets Quality control
Details
Stability analysis of compound menthol nasal drops under different packaging materials and storage conditions

Published on Frontiers in Pharmaceutical Sciences 2026,30(7):1155-1162.
493 times 113 times

WANG Qiulan HAN Hong CAI Yue XIONG Wei XIE Xuejia

Compound menthol nasal drops Packaging materials Storage conditions Gas chromatography Camphor Menthol Statistical analysis
Details
Mechanistic study on chitosan-mediated adsorption for regulating the migration of lead and cadmium in an eczema external wash formula

Published on Frontiers in Pharmaceutical Sciences 2026,30(7):1147-1154.
476 times 115 times

ZHI Hui WANG Zhonghua LIU Xixian

Eczema external wash formula Heavy metals Pb Cd Adsorption Removal Migration
Details
Optimization of integrated processing technology for Acorus tatarinowii production area based on Box-Behnken response surface methodology combined with CRITIC method

Published on Frontiers in Pharmaceutical Sciences 2026,30(7):1139-1146.
543 times 128 times

WU Shengzhen ZHANG Yu WU Xiangwei SONG Lifang WU Suzhen

Acorus tatarinowii Integrated production and processing Processing CRITIC method Box-Behnken design-response surface methodology
Details
Determination of multiple mutagenic impurities in rotigotine by LC-MS/MS and GC-MS

Published on Frontiers in Pharmaceutical Sciences 2026,30(7):1132-1138.
459 times 121 times

WANG Weijiao TANG Haozheng TIAN Jialin CHEN Hongyu

Rotigotine Mutagenic impurities p-toluenesulfonate esters 1-iodopropane LC-MS/MS GC-MS
Details
Establishment of a UPLC fingerprint and multi-component quantitation method for Lycii Fructus

Published on Frontiers in Pharmaceutical Sciences 2026,30(7):1123-1131.
485 times 135 times

LUO Qun JIN Hongyu LI Wei WANG Ying LIN Yongqiang

Lycii Fructus Fingerprint Content determination Rutin Kaempferol-3-O-rutinoside Narcissin Principal component analysis Hierarchical cluster analysis
Details
Optimization of flavonoid extraction conditions from Polygonatum cyrtonema by orthogonal test combined with particle swarm optimization and distribution patterns in different organs

Published on Frontiers in Pharmaceutical Sciences 2026,30(7):1112-1122.
464 times 137 times

SHEN Yuan LIANG Qiao PAN Wenyun LI Chunxiao LI Keying ZHANG Xianwen ZHONG Junfang FAN Baolei

Polygonatum cyrtonema Flavonoids Particle swarm optimization algorithm HPLC Principal component analysis Cluster analysis Spearman correlation analysis
Details
Effects of decitabine and DNMT1 silencing on the expression and methylation of LINC00472 in osteosarcoma MG-63 cells

Published on Frontiers in Pharmaceutical Sciences 2026,30(7):1102-1111.
442 times 125 times

ZOU Qiong YANG Yanming REN Danyang TU Caixia SHEN Jianling GAO Lihui LI Fashuang ZHANG Lilin LI Huiying

LINC00472 Decitabine DNMT1 Methylation Osteosarcoma MG-63 cells
Details
Preliminary analysis of the multi-index components determination and antitussive mechanism of Kelu oral liquid by HPLC and network pharmacology

Published on Frontiers in Pharmaceutical Sciences 2026,30(7):1092-1101.
497 times 150 times

HE Jingxia XU Gang ZHANG Xiaoxiao GONG Deling LIU Yangyang WANG Xiaomei

Kelu oral liquid Network pharmacology Antitussive Multi-index components HPLC Mechanism
Details